Latest Harry L. Leider Stories
BALTIMORE, March 17, 2011 /PRNewswire/ -- Patients undergoing opioid therapy for chronic pain who may not be following their prescription regimen have significantly higher overall healthcare costs, Ameritox Ltd. announced recently. The study was published in The American Journal of Managed Care.
Ameritox, the U.S. leader in pain prescription monitoring, is pleased to announce that Dr. Harry L. Leider, MD, MBA, FACPE, has joined the company as chief medical officer and senior vice president. Dr.
- An imitative word; an onomatopoetic word.